Clinical Trials in Philadelphia

Showing 4661-4680 of 20,904 trials

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

NCT02614547

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy, safety, and pharmacokinetics of SAGE-547 Injection in adult female participants diagnosed with severe postpartum depression.

Severe Postpartum Depression

Supernus Pharmaceuticals, Inc.21 participantsStarted Dec 2015

Atlanta, Georgia, United States • Worcester, Massachusetts, United States • Chapel Hill, North Carolina, United States +1 more locations

RECRUITING< 1 mile

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

NCT02523118

The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN and EoC normally undergo endoscopy and/or colonoscopy where cells are collected for microscopic analysis. Treatments are then decided based on how the cells look. We are aiming to compare different tissue components such as inflammatory cell types with clinical symptoms. We want to see if scores on standard questionnaires can give us an idea how well the person is doing.

Eosinophilic Gastrointestinal Disorders (EGIDs)Eosinophilic EsophagitisEosinophilic Gastritis+2 more

Children's Hospital Medical Center, Cincinnati1,350 participantsStarted Jul 2015

Phoenix, Arizona, United States • Rogers, Arkansas, United States • San Diego, California, United States +16 more locations

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

Find Trials by Condition in Philadelphia

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

Development/Testing of SUMMIT: a Tool to Help Patients Manage Pain While Tapering Opioids

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex

Biofeedback Based Virtual Reality Intervention to Manage Postoperative Pain

Prevention and Treatment of Patient Before, During, and After Covid-19 Infection

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

Periprosthetic Fracture Registry (PPFx)

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Use of Dalfampridine in Primary Lateral Sclerosis

Nature IDEAS Study: An RCT to Increase Time Spent in Nature Among University Students

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

SPRINT: Signature for Pain Recovery IN Teens

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)